Effect of RGPU-260, a Novel GABA Derivative, on Functional Reserves of Rat Heart after Chronic Alcohol Intoxication

Area of Science:

• Cardiology
• Pharmacology
• Toxicology

Background:

• Chronic alcohol intoxication significantly impairs cardiac contractility.
• Alcohol-induced heart dysfunction is characterized by reduced myocardial contraction and relaxation rates.
• Existing treatments may have limitations in addressing alcohol-related cardiac damage.

Purpose of the Study:

• To evaluate the cardiotropic effects of RGPU-260, a novel GABA derivative.
• To assess the efficacy of RGPU-260 in mitigating cardiac dysfunction caused by chronic alcohol exposure.
• To compare the effectiveness of RGPU-260 with the reference drug mildronate.

Main Methods:

• Rats were subjected to chronic alcohol intoxication (10% ethanol for 24 weeks).
• Cardiac function was assessed through measurements of myocardial contraction/relaxation rates (+dP/dtmax, -dP/dtmax) and left ventricular pressure under various load conditions.
• RGPU-260 was administered daily (25 mg/kg, intragastrically) for 14 days to a subset of alcohol-exposed rats.

Main Results:

• Alcohol-intoxicated rats exhibited significantly reduced cardiac contractility and relaxation compared to intact rats.
• Treatment with RGPU-260 led to significant improvements in myocardial contraction and relaxation rates.
• The cardiotropic effects of RGPU-260 were comparable to those observed with mildronate treatment.

Conclusions:

• RGPU-260 demonstrates a positive cardiotropic effect, effectively improving cardiac contractility in the context of chronic alcohol intoxication.
• RGPU-260 shows potential as a therapeutic agent for alcohol-induced cardiac dysfunction.
• The efficacy of RGPU-260 is comparable to established treatments like mildronate.